论文部分内容阅读
哌拉西林钠(Piperacillin Sodium)为第三代半合成广谱青霉素。我院呼吸内科应用山西同领药业有限公司生产的哌拉西林钠粉针治疗急性下呼吸道感染60例与同期应用的阿莫西林治疗40例进行比较,疗效显著,现报告如下。1 材料与方法1.1 病例选择:自1998年1月至10月在我院因急性下呼吸道感染而住院治疗的100例患者作为入选对象。100例患者随机分为两组,两组患者的病种分布和病情严重程度基本相似。治疗组60例,其中男38例,女22例,患者平均年龄57.8岁(25～76岁)。对照组40例,其中男24例,女16例,患者平均年龄57岁(18～78岁)。两组患者患病中类见表1。
Piperacillin Sodium is the third generation semi-synthetic broad spectrum penicillin. The Department of Respiratory Medicine in our hospital Shanxi Tongling Pharmaceutical Co., Ltd. produced piperacillin sodium powder in the treatment of acute lower respiratory tract infection in 60 cases with the same period of treatment of amoxicillin in 40 cases compared to a significant effect, are as follows. 1 Materials and Methods 1.1 Case Selection: From January 1998 to October in our hospital due to acute lower respiratory tract infection and hospitalization of 100 patients were enrolled. 100 patients were randomly divided into two groups, the distribution of the two groups of patients and the severity of the disease are basically similar. The treatment group of 60 patients, 38 males and 22 females, the average age of 57.8 years (25 to 76 years). The control group of 40 patients, including 24 males and 16 females, the average age of patients 57 years (18 to 78 years old). The prevalence of two groups of patients in Table 1.